Real-time enrollment status for this recurrent diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:47 AM UTC
| NCT Number | NCT06784726 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Diffuse Large B-Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Washington |
| Last Updated on CT.gov | May 6, 2026 (May 6, 2026) |
As of July 17, 2026: Clinical trial NCT06784726 is currently recruiting participants. This phase2 study for recurrent diffuse large b-cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Washington. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06784726 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06784726 was last updated May 6, 2026 (May 6, 2026). HelloStudys verifies this status automatically.